Clinical Trials Directory

Trials / Completed

CompletedNCT06029842

The Role of a Clinical Pharmacist in the Management of Type 2 Diabetic Patients in a Primary Medical Center in Jordan

A Randomized Controlled Trial to Assess the Role of a Clinical Pharmacist in the Management of Type 2 Diabetic Patients for Optimum Treatment Outcomes in a Primary Medical Center in Jordan

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
103 (actual)
Sponsor
University of Jordan · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study aimed to assess the impact of the clinical pharmacist on enhancing type 2 diabetic patients outcomes in a primary health care center.

Detailed description

About 103 patients with type 2 diabetes were randomized to control or intervention group, the control group received a standard care, while the intervention group received the collaborative care between the clinical pharmacist and physicians. Fasting blood glucose, HbA1c, Lipid profile, and blood pressure measured for both groups at baseline and after three months of follow-up. Treatment related problems (TRPs), quality of life, adherence, and patients knowledge about their medications were assessed. Cost avoidance and clinical significance of implemented clinical pharmacist interventions were assessed too.

Conditions

Interventions

TypeNameDescription
OTHERCollaborative approach of clinical pharmacist with physicians in a medical centerFor those who allocated to the intervention group, the clinical pharmacist interviewed them at each monthly visit about 30 minutes before seeing physicians, the clinical pharmacist identified treatment related problems, provided medication counseling, answered questions asked by patients or physicians, encouraged compliance, offered instructions on self-monitoring of blood pressure and glucose levels, distributed educational materials about diabetes and emphasis was made on optimizing adherence to pharmacological and non- pharmacological therapy. the pharmacist interventions on treatment related problems (TRPs) and proposed patient care plans were discussed with treatng physicians who decided to accept or reject them.

Timeline

Start date
2022-10-17
Primary completion
2023-04-24
Completion
2023-04-24
First posted
2023-09-08
Last updated
2024-11-21

Locations

1 site across 1 country: Jordan

Source: ClinicalTrials.gov record NCT06029842. Inclusion in this directory is not an endorsement.